Restricted accessResearch articleFirst published online 2013-02
Influenza Virus Subpopulations: Interferon Induction-Suppressing Particles Require Expression of NS1 and Act Globally in Cells;UV Irradiation of Interferon-Inducing Particles Blocks Global Shut-Off and Enhances Interferon Production
Influenza virus populations contain several subpopulations of noninfectious biologically active particles that are measured by the unique phenotypes they express. Two of these subpopulations were studied: (1) interferon (IFN)-inducing particles (IFP) and (2) IFN induction-suppressing particles (ISP). ISP are dominant in cells coinfected with one or more IFP; they completely suppress IFN production in cells otherwise programmed to induce it. Influenza virus ISP were shown to act in host cells in a nonspecific and global manner, suppressing IFN induction independent of the family of viruses serving as IFN inducers. ISP must be present within the first 3 h of coinfection with IFP to be maximally effective; by 7 hpi IFN induction/production is refractory to the action of superinfecting ISP. UV target and thermal inactivation analyses revealed that ISP activity was dependent solely on the expression of the NS gene. Low doses of UV radiation enhanced by ∼10-fold the already high IFN-inducing capacity of a virus that expressed truncated NS1. There was no change in the number of IFP, implying that the production of IFN/cell had increased. We postulated that preventing degradation of cellular RNA pol II by viral polymerase prolonged the transcription of cellular mRNA, including IFN mRNA, to enhance the IFN-inducing capacity of the cell without any increase in the number of IFP. These studies point to the dueling roles of IFP and ISP in modulating IFN induction/production, the former activity being critical to the efficacy of live attenuated influenza vaccines.
Get full access to this article
View all access options for this article.
References
1.
BelsheRB, EdwardsKM, VesikariT, BlackSV, WalkerRE, HultquistM, KembleG, ConnorEM. 2007. Live attenuated versus inactivated influenza vaccine in infants and young children. N Engl J Med, 356:685–696.
2.
BracciL, CaniniI, PuzelliS, SestiliP, VendittiM, SpadaM, DonatelliI, BelardelliF, ProiettiE. 2005. Type I IFN is a powerful mucosal adjuvant for a selective intranasal vaccination against influenza virus in mice and affects antigen capture at mucosal level. Vaccine, 23:2994–3004.
3.
BrownleeGG, SharpsJL. 2002. The RNA polymerase of influenza A virus is stabilized by interaction with its viral RNA promotor. J Virol, 76:7103–7113.
4.
BurkeDC, BuchanA. 1965. Interferon production in chick embryo cells. I. Production by ultraviolet-inactivated virus. Virology, 26:28–35.
5.
CauthenAN, SwayneDE, SekellickMJ, MarcusPI, SuarezDL. 2007. Amelioration of influenza virus pathogenesis in chickens attributed to the enhanced interferon-inducing capacity of a virus with a truncated NS1 gene. J Virol, 81:1838–1847.
6.
DesselbergerU. 1975. Relation of virus particle counts to the hemagglutinating activity of influenza virus suspensions measured by the HA pattern test and by use of the photometric HCU method. Arch Virol, 49:365–372.
7.
DonaldHB, IsaacsA. 1954. Counts of influenza virus particles. J Gen Microbiol, 10:457–464.
8.
DrakeJW. 1993. Rates of spontaneous mutation among RNA viruses. Proc Natl Acad Sci U S A, 90:4171–4175.
9.
GathererD. 2009. The 2009 H1N1 influenza outbreak in its historical context. J Clin Virol, 45:174–178.
10.
GorseGJ, CampbellMJ, OttoEE, PowersDC, ChambersGW, NewmanFK. 1995. Increased anti-influenza A virus cytotoxic T cell activity following vaccination of the chronically ill elderly with live attenuated or inactivated influenza virus vaccine. J Infect Dis, 172:1–10.
11.
GraefKM, VreedeFT, LauY-F, McCallAW, CarrSM, SubbaraoK, FodorE. 2010. The PB2 subunit of the influenza virus RNA polymerase affects virulence by interacting with the mitochondrial antiviral signaling protein and inhibiting expression of beta interferon. J Virol, 84:8433–8445.
IsaacsA, LindenmannJ. 1957. Viral interference. I. The Interferon. Proc Roy Soc B, 147:258–267.
14.
IwaiA, ShiozakiT, KawaiT, AkiraS, KawaokaY, TakadaA, KidaH, MiyazakiT. 2010. Influenza A virus polymerase inhibits type I interferon induction by binding to interferon beta promoter stimulator 1. J Biol Chem, 285:32064–32074.
15.
LylesDS. 2000. Cytopathogenesis and inhibition of host gene expression in RNA viruses. Microbiol Mol Biol Rev, 64:709–724.
16.
MalinoskiCP, MarcusPI. 2012. Influenza virus: A single noninfectious interferon induction-suppressing particle blocks expression of interferon-inducing particles. J Interferon Cytokine Res, 32,3:121–126.
17.
MarcusPI. 1983. Interferon induction by viruses: one molecule of dsRNA as the threshold for interferon induction. GresserI. Interferon 5. London UK: Academic Press, 115–180.
MarcusPI, GirshickT, van der HeideL, SekellickMJ. 2007. Super-sentinel chickens and detection of low-pathogenicity influenza virus. Emerg Infect Dis, 13:1608–1610.
20.
MarcusPI, NgunjiriJM, SekellickMJ. 2009. Dynamics of biologically active subpopulations of influenza virus: plaque-forming, noninfectious cell-killing, and defective interfering particles. J Virol, 83:8122–8130.
21.
MarcusPI, NgunjiriJM, SekellickMJ, WangL, LeeC-W. 2010. In vitro analysis of virus particle subpopulations in candidate live-attenuated influenza vaccines distinguishes effective from ineffective vaccines. J Virol, 84:10974–10981.
22.
MarcusPI, RojekJM, SekellickMJ. 2005. Interferon induction and/or production and its suppression by influenza A viruses. J Virol, 79:2880–2890.
23.
MarcusPI, SekellickMJ. 1975. Cell killing by viruses. II. Cell killing by vesicular stomatitis virus:a requirement for virion-derived transcription. Virology, 63:176–190.
24.
MarcusPI, SekellickMJ. 1985. Interferon induction by viruses. XIII. Detection and assay of interferon induction-suppressing particles. Virology, 142:411–415.
25.
MuellerSN, LangleyWA, CarneroE, García-SastreA, AhmedR. 2010. Immunization with live attenuated influenza viruses that express altered NS1 proteins results in potent and protective memory CD8+ T-cell responses. J Virol, 84:1847–1855.
26.
MurtiKG, WebsterRG, JonesIM. 1988. Localization of RNA polymerases on influenza viral ribonucleoproteins by immunogold labeling. Virology, 164:562–566.
NelsonKM, SchramBR, McGregorMW, SheoranAS, OlsenCW, LunnDP. 1998. Local and systemic isotype-specific antibody responses to equine influenza virus infection versus conventional vaccination. Vaccine, 16:1306–1313.
29.
NgunjiriJM, LeeC-W, AliA, MarcusPI. 2012a. Influenza virus interferon-inducing particle efficiency is reversed in avian and mammalian cells, and enhanced in cells co-infected with defective-interfering particles. J Interferon Cytokine Res, 32,6:280–285.
30.
NgunjiriJM, MohniKN, SekellickMJ, Schultz-CherryS, WebsterRG, MarcusPI. 2012b. Lethal H5N1 influenza viruses are not resistant to interferon action in human, simian, porcine, or chicken cells. Nat Med, 18,10:1456–1457.
31.
NgunjiriJM, SekellickMJ, MarcusPI. 2008. Clonogenic assay of type A influenza viruses reveals noninfectious cell-killing (apoptosis-inducing) particles. J Virol, 82:2673–2680.
32.
PlotchSJ, BouloyM, UlmanenI, KrugRM. 1981. A unique cap (m7GpppXm)-dependent influenza virion endonuclease cleaves capped RNAs to generate the primers that initiate viral RNA transcription. Cell, 23:847–858.
33.
RichtJA, García-SastreA. 2009. Attenuated influenza virus vaccines with modified NS1 proteins. Curr Top Microbiol Immunol, 333:177–195.
34.
RodriguezA, Pérez-GonzálezA, HossainMJ, ChenL-M, RollingT, Pérez-BreñaP, DonisR, KochsG, NietoA. 2009. Attenuated strains of influenza A viruses do not induce degradation of RNA polymerase II. J Virol, 83:11166–11174.
35.
RodriguezA, Pérez-GonzálezA, NietoA. 2007. Influenza virus infection causes specific degradation of the largest subunit of cellular RNA polymerase II. J Virol, 81:5315–5324.
36.
SchwarzH, HarlinO, OhnemusA, KaspersB, StaeheliP. 2004. Synthesis of IFN-beta by virus-infected chicken embryo cells demonstrated with specific antisera and a new bioassay. J Interferon Cytokine Res, 24,3:179–184.
37.
SekellickMJ, BiggersWJ, MarcusPI. 1990. Development of the interferon system. I. In chicken cells development in ovo continues on time in vitro. In Vitro Cell Dev Biol, 26:997–1003.
38.
SekellickMJ, CarraSA, BowmanA, HopkinsDA, MarcusPI. 2000. Transient resistance of influenza virus to interferon action attributed to random multiple packaging and activity of NS genes. J Interferon Cytokine Res, 20:963–970.
SekellickMJ, MarcusPI. 1986. Induction of high titer chicken interferon. Methods Enzymol, 119:115–125.
41.
ShawML, PaleseP. 2007. Orthomyxoviridae: the viruses and their replication. KnipeDM, HowleyPM. Fields virology, 5th. Philidelphia, PA: Lippincott Williams & Wilkins. II,Chap. 447:1647–1689.
42.
SuarezDL, GarciaM, LatimerJ, SenneD, PerdueM. 1999. Phylogenetic analysis of H7 avian influenza viruses isolated from the live bird markets of the Northeast United States. J Virol, 73:3567–3573.
43.
SuarezDL, PerdueML. 1998. Multiple alignment comparison of the non-structural genes of influenza A viruses. Virus Res, 54:59–69.
44.
VersteegGA, Garcia-SastreA.2011. Influenza virus and interferons. MossmanK. Viruses and interferon, current research. Norfolk, UK: Caister Academic PressChapter 8:181–214.
45.
VreedeFT, ChanAT, SharpsJ, FodorE.2010. Mechanisms and functional implications of the degradation of host RNA polymerase II in influenza virus infected call. Virology, 396:125–134.
46.
VreedeFT, FodorE. 2010. The role of the influenza virus RNA polymerase in host shut-off. Virulence, 1:436–439.
47.
WangL, SuarezDL, Pantin-JackwoodM, MibayashiM, García-SastreA, SaifYM, LeeC-W. 2008. Characterization of influenza virus variants with different sizes of the non-structural (NS) genes and their potential as a live influenza vaccine in poultry. Vaccine, 26:3580–3586.
48.
WebsterRG. 1998. Influenza: an emerging disease. Emerg Infect Dis, 4:436–441.
